118000.KS
Metacare Co., Ltd.
KSC · Healthcare · Drug Manufacturers - General · KR
KRW 1,298.00
−1.67%Year over year
Reported trailing growth
- Revenue
- +73.1%
- EBITDA
- -32.0%
- EBIT
- +5.8%
- EPS
- —
- Free cash flow
- +32.0%
- Operating cash flow
- -6.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.8%
- EBITDA
- +21.1%
- EBIT
- +14.9%
- Net income
- -94.6%
- EPS
- -95.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026